{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:05:04Z","timestamp":1790028304859,"version":"4.0.1"},"reference-count":125,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Glaxo Smith Kline"},{"name":"Gut Research Services BV"},{"DOI":"10.13039\/100013207","name":"Reckitt Benckiser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013207","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GenDX"},{"name":"Galvani Bioelectronics BV"},{"name":"Takeda"},{"DOI":"10.13039\/501100012276","name":"Tillotts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pliant"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jhep.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T20:45:45Z","timestamp":1558125945000},"page":"603-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis"],"prefix":"10.1016","volume":"71","author":[{"given":"Manon","family":"de Krijger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon E.","family":"Wildenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyriel Y.","family":"Ponsioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.05.006_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0035-1571274","article-title":"New therapeutic strategies for primary sclerosing cholangitis","volume":"36","author":"Williamson","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2019.05.006_b0010","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0020","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977\u20132011.","author":"Sorensen","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.05.006_b0025","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/MEG.0000000000000660","article-title":"Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands","volume":"28","author":"de Groof","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.006_b0035","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2019.05.006_b0040","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2019.05.006_b0045","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ibd.21569","article-title":"Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea","volume":"17","author":"Ye","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2019.05.006_b0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.crohns.2013.12.007","article-title":"Outcomes after ileal pouch anal anastomosis in patients with primary sclerosing cholangitis","volume":"8","author":"Pavlides","year":"2014","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jhep.2019.05.006_b0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.006_b0060","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","author":"Ji","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2019.05.006_b0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2019.05.006_b0070","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.006_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izx096","article-title":"Natural history of established and de novo inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","author":"Mouchli","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2019.05.006_b0080","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"Jorgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2019.05.006_b0085","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2036.2012.05063.x","article-title":"The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis","volume":"35","author":"Navaneethan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.05.006_b0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/apt.14393","article-title":"Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients","volume":"47","author":"Nordenvall","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.05.006_b0095","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cgh.2012.01.006","article-title":"Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis","volume":"10","author":"Navaneethan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0100","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2010.235408","article-title":"Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?","volume":"60","author":"Marelli","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.006_b0105","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/j.1478-3231.2011.02635.x","article-title":"Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis","volume":"31","author":"Mueller","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2019.05.006_b0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0115","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0120","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.145.10.3247","article-title":"Differential expression of homing-associated adhesion molecules by T cell subsets in man","volume":"145","author":"Picker","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2019.05.006_b0130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nri1222","article-title":"Homing and cellular traffic in lymph nodes","volume":"3","author":"von Andrian","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.10.046","article-title":"Leukocyte trafficking to the small intestine and colon","volume":"150","author":"Habtezion","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0140","first-page":"97","article-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","volume":"151","author":"Briskin","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2019.05.006_b0145","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2015.12.002","article-title":"Gut \u2013 liver immunity","volume":"64","author":"Trivedi","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0150","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1084\/jem.20080414","article-title":"Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans","volume":"205","author":"Jaensson","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2019.05.006_b0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1440-1827.2002.01365.x","article-title":"Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease","volume":"52","author":"Arihiro","year":"2002","journal-title":"Pathol Int"},{"key":"10.1016\/j.jhep.2019.05.006_b0165","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0016-5085(92)90015-Q","article-title":"Expression of vascular adhesion molecules in inflammatory bowel disease","volume":"103","author":"Koizumi","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MIB.0000000000001029","article-title":"The alpha4beta1 homing pathway is essential for ileal homing of crohn's disease effector T cells in vivo","volume":"23","author":"Zundler","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2019.05.006_b0175","article-title":"Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease","author":"Zeissig","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.006_b0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0185","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ni1504","article-title":"Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10","volume":"8","author":"Maynard","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.192.5.761","article-title":"Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity","volume":"192","author":"Kunkel","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0195","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2016.01.001","article-title":"Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity","volume":"68","author":"Trivedi","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2019.05.006_b0200","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.4049\/jimmunol.165.9.5069","article-title":"The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system","volume":"165","author":"Papadakis","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni.3079","article-title":"Role and species-specific expression of colon T cell homing receptor GPR15 in colitis","volume":"16","author":"Nguyen","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0210","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.1237013","article-title":"GPR15-mediated homing controls immune homeostasis in the large intestine mucosa","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jhep.2019.05.006_b0215","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI17244","article-title":"CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells","volume":"111","author":"Kunkel","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2019.05.006_b0220","doi-asserted-by":"crossref","first-page":"G1062","DOI":"10.1152\/ajpgi.00162.2004","article-title":"Regulated production of the chemokine CCL28 in human colon epithelium","volume":"287","author":"Ogawa","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2019.05.006_b0225","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal0180","article-title":"A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia","volume":"10","author":"Suply","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/j.jhep.2019.05.006_b0230","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3389\/fimmu.2017.01111","article-title":"A Mucosal and cutaneous chemokine ligand for the lymphocyte chemoattractant receptor GPR15","volume":"8","author":"Ocon","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0235","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1172\/JCI119468","article-title":"A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature","volume":"99","author":"Wong","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2019.05.006_b0240","first-page":"481","article-title":"Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3","volume":"142","author":"Steinhoff","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2019.05.006_b0245","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2007.12.005","article-title":"Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs","volume":"48","author":"Lee","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0250","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.169.2.983","article-title":"Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells","volume":"169","author":"Lalor","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0255","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the liver by intravascular effector CD8(+) T cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2019.05.006_b0260","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4049\/jimmunol.177.1.593","article-title":"Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10","volume":"177","author":"Eksteen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9440(10)62060-3","article-title":"CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow","volume":"167","author":"Curbishley","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2019.05.006_b0270","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/hep.26965","article-title":"Vascular cell adhesion molecule 1 expression by biliary epithelium promotes persistence of inflammation by inhibiting effector T-cell apoptosis","volume":"59","author":"Afford","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0275","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00042737-199907000-00015","article-title":"Immunohistochemical analysis of inflammation in primary sclerosing cholangitis","volume":"11","author":"Ponsioen","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0285","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2009.02.046","article-title":"Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells","volume":"137","author":"Eksteen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0290","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26702","article-title":"CD8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice","volume":"59","author":"Seidel","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0295","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jhep.2014.02.011","article-title":"Influence of CD8 T cell priming in liver and gut on the enterohepatic circulation","volume":"60","author":"Eickmeier","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0300","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/hep.24816","article-title":"Connecting liver and gut: murine liver sinusoidal endothelium induces gut tropism of CD4+ T cells via retinoic acid","volume":"55","author":"Neumann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0305","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjx050","article-title":"Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease","author":"Gwela","year":"2017","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jhep.2019.05.006_b0310","article-title":"CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood","author":"Schoknecht","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2019.05.006_b0315","article-title":"High serum sCD40 and a distinct colonic T-cell profile in ulcerative colitis associated with primary sclerosing cholangitis","author":"Lampinen","year":"2018","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jhep.2019.05.006_b0320","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.04.003","article-title":"Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis","volume":"147","author":"Liaskou","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0325","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1002\/art.21353","article-title":"Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis","volume":"52","author":"Bryl","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2019.05.006_b0330","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2019.05.006_b0335","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0340","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1400861","article-title":"IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-beta receptor on hepatic stellate cells in a JNK-dependent manner","volume":"193","author":"Fabre","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0345","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0350","first-page":"988","article-title":"Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases","volume":"23","author":"Martins","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0355","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.02.019","article-title":"Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic gammadelta T-cell receptor-positive cells and pathogenesis of cholestatic liver disease","author":"Tedesco","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2019.05.006_b0365","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","article-title":"Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function","volume":"172","author":"Thornton","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.22591","article-title":"Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-\/-) mice","volume":"49","author":"Hsu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0375","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.4049\/jimmunol.1800711","article-title":"Colitis promotes a pathological condition of the liver in the absence of Foxp3(+) regulatory T cells","volume":"201","author":"Mathies","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0380","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0385","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00535-010-0199-3","article-title":"Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases","volume":"45","author":"Koyabu","year":"2010","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2019.05.006_b0390","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhep.2016.09.002","article-title":"Gut and liver T cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease","volume":"66","author":"Henriksen","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0395","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/gast.2001.27968","article-title":"Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans","volume":"121","author":"Salmi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0400","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1478-3231.1999.tb00084.x","article-title":"Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease","volume":"19","author":"Hillan","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2019.05.006_b0405","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1007\/s10620-013-2755-1","article-title":"Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates","volume":"58","author":"Ala","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2019.05.006_b0410","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.24085","article-title":"Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity","volume":"53","author":"Liaskou","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0415","doi-asserted-by":"crossref","first-page":"C1096","DOI":"10.1152\/ajpcell.2001.281.4.C1096","article-title":"Regulation and distribution of MAdCAM-1 in endothelial cells in vitro","volume":"281","author":"Oshima","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jhep.2019.05.006_b0420","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1073\/pnas.92.8.3561","article-title":"Induction of the gene encoding mucosal vascular addressin cell adhesion molecule 1 by tumor necrosis factor alpha is mediated by NF-kappa B proteins","volume":"92","author":"Takeuchi","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2019.05.006_b0425","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/gut.40.2.241","article-title":"Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation","volume":"40","author":"Meenan","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.006_b0430","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1124\/jpet.109.153973","article-title":"The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases","volume":"330","author":"Soler","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2019.05.006_b0435","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0002-9440(10)62570-9","article-title":"Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease","volume":"160","author":"Grant","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2019.05.006_b0440","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201847965","article-title":"CCL21-expression and accumulation of CCR7(+) NK cells in livers of patients with primary sclerosing cholangitis","author":"Langeneckert","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0445","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0450","article-title":"High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease","author":"Govaere","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2019.05.006_b0455","doi-asserted-by":"crossref","first-page":"G1257","DOI":"10.1152\/ajpgi.00266.2007","article-title":"CCL25 and CCL28 promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow","volume":"294","author":"Miles","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2019.05.006_b0460","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.LAB.0000067498.89585.06","article-title":"Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases","volume":"83","author":"Terada","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2019.05.006_b0465","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2010-09-311076","article-title":"Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer","volume":"118","author":"Aalto","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.05.006_b0470","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1182\/blood-2009-04-219253","article-title":"Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate","volume":"114","author":"Kivi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2019.05.006_b0475","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1084\/jem.178.6.2255","article-title":"Induction and function of vascular adhesion protein-1 at sites of inflammation","volume":"178","author":"Salmi","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0480","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/hep.21497","article-title":"Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion","volume":"45","author":"Lalor","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0485","article-title":"Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner","author":"Trivedi","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.006_b0490","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1172\/JCI73722","article-title":"Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis","volume":"125","author":"Weston","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2019.05.006_b0495","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1073\/pnas.1322731111","article-title":"Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis","volume":"111","author":"Nakagawa","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2019.05.006_b0500","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/156652409789105525","article-title":"Role of beta7 integrins in intestinal lymphocyte homing and retention","volume":"9","author":"Gorfu","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0505","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002510050422","article-title":"The beta7 integrin gene (Itgb-7) promoter is responsive to TGF-beta1: defining control regions","volume":"48","author":"Lim","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jhep.2019.05.006_b0510","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/eji.200425125","article-title":"CCL25\/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes","volume":"34","author":"Ericsson","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2019.05.006_b0515","first-page":"237","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","author":"Liver. EAftSot","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0520","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0525","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0530","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4161\/mabs.26392","article-title":"In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes","volume":"5","author":"Wyant","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.jhep.2019.05.006_b0535","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0540","first-page":"400","article-title":"Long-term efficacy of vedolizumab for ulcerative colitis","volume":"11","author":"Loftus","year":"2017","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jhep.2019.05.006_b0545","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0550","first-page":"412","article-title":"Long-term efficacy of vedolizumab for Crohn's disease","volume":"11","author":"Vermeire","year":"2017","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.jhep.2019.05.006_b0555","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/apt.14525","article-title":"Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease","volume":"47","author":"Christensen","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2019.05.006_b0560","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1097\/MIB.0000000000000906","article-title":"Vedolizumab in inflammatory bowel disease associated with autoimmune liver disease pre- and postliver transplantation: a case series","volume":"22","author":"Lim","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2019.05.006_b0565","article-title":"Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases","author":"Lynch","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2019.05.006_b0570","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220351","article-title":"Vedolizumab: a novel medical intervention in the treatment of primary sclerosing cholangitis","volume":"2017","author":"Westerveld","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jhep.2019.05.006_b0575","doi-asserted-by":"crossref","unstructured":"Caron LP-B, Nachury M, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R, Reenaers C, Serrero M, Boureille A, Nancey S, Filippi J, Abitbol V, Savoye G, Vuitton L, Viennot S, Fumery M, Reymond M, Bronowicki JP, Reimund J-M, Amiot A. Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID. Concres abstract, ECCO 2018. 2018.","DOI":"10.1093\/ecco-jcc\/jjx180.474"},{"key":"10.1016\/j.jhep.2019.05.006_b0580","first-page":"S598","article-title":"Efficacy and safety of abrilumab (AMG 181\/MEDI 7183) therapy for moderate to severe Crohn\u2019s disease","volume":"152","author":"Sandborn","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0585","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/j.gastro.2018.11.035","article-title":"Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis","volume":"156","author":"Sandborn","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2019.05.006_b0590","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(14)60661-9","article-title":"Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial","volume":"384","author":"Vermeire","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2019.05.006_b0595","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(17)30930-3","article-title":"Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"390","author":"Vermeire","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2019.05.006_b0600","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/gutjnl-2016-313457","article-title":"Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study","volume":"67","author":"Sandborn","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.006_b0605","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015081","article-title":"Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): a single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol","volume":"7","author":"Arndtz","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhep.2019.05.006_b0610","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.05.006_b0615","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30509","article-title":"The nonsteroidal farnesoid X receptor agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with primary sclerosing cholangitis","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.006_b0620","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1073\/pnas.1524890113","article-title":"Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis","volume":"113","author":"Ho","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2019.05.006_b0625","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/apt.13398","article-title":"Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease","volume":"42","author":"Feagan","year":"2015","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819302879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827819302879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:36:17Z","timestamp":1759174577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827819302879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0168827819302879"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.05.006","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}